By proceeding, you agree to our Terms of Use and Privacy Policy.
Chair of FDA review committee for Kymriah, the first CAR-T BLA. 10 years of FDA cellular and gene therapy review experience. 7 years of R&D experience at VIRxSYS Corp. Postdoctorate at UCSF.Ph.D. from State University of New York. US based.
Talks About #technology #it
Preferred Locations #NorthAmerica
In the context of ever-important gene therapy scale-up to achieve commercial goals and mounting regulatory scrutiny, the 3rd Annual Gene Therapy Comparability Summit is the only event focused on comparability of gene therapy.
